Central Govt full stop to doctor-pharma nexus- Curtails MR visits in Govt hospitals
New Delhi: Putting an end to the unholy doctor pharma nexus aimed at unethically promoting and prescribing certain pharma brands, the Union Government has completely curtailed the visits of pharma company Medical Representatives (MRs) to Government Hospital premises. Besides this, the Government has strictly stipulated that information about any new launch should be communicated via email.
The direction came in the form of a recent office order issued by Dr Atul Goel, Director General Health Services (DGHS) and the Central Government Hospitals/CGHS Wellness Centers/ Polyclinics.
This comes in the light of the fact that all doctors across the country have been mandated by the erstwhile Medical Council of India (now National Medical Commission (NMC)) to prescribe generic medicines only. However, the Central Government noted that in various Central Government Hospitals/CGHS Wellness Centers/ Polyclinics there were many doctors (including Residents) who continued to prescribe branded medicines.
Taking cognizance, the Ministry of Health and Family Welfare issued an office order directing all the head of the institutions to ensure strict compliance by the doctors working under them. The order read;
"It is to be noted that all doctors in the Central Government Hospitals/CGHS Wellness Centers/ Polyclinics have been instructed time and again to prescribe generic medicines ONLY. Despite this, it has been observed that doctors (including Residents) in some instances has continued to prescribe branded medicines. This has been viewed strictly by the competent authorities.
This may be noted by all head of institutions and they may ensure strict compliance by the doctors working under them if anyone continues to be non-complaint he/she shall be liable for further action," the order added.
The order further called for complete curtailment of visits of pharma company MRs to these institutions. The order said;
"Further, it may be ensured that visits of Medical Representatives (MRs) to hospitals premises are completely curtailed. Any information about new launch may be communicated by way of email only, "
The Government has been working on cracking down the unethical doctor-pharma nexus since long and had earlier suspended two central government health scheme (CGHS) doctors for allegedly prescribing certain medicines in favour of a particular pharmaceutical company.
Medical Dialogues had earlier reported that the Ethics and Medical Registration Board (EMRB) of NMC in the draft Registered Medical Practitioner (Professional Conduct) Regulations, 2022, stated that the doctors should prescribe medicines with "generic"/"non-proprietary"/"pharmacological" names only.
The prescription guidelines that form an integral part of the Draft had mentioned, "Prescribe only those generic medicines that are available in the market and accessible to the patient."
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.